Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,325 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Reasons for multiple biologic and targeted synthetic DMARD switching and characteristics of treatment refractory rheumatoid arthritis.
McDermott GC, DiIorio M, Kawano Y, Jeffway M, MacVicar M, Dahal K, Moon SJ, Seyok T, Coblyn J, Massarotti E, Weinblatt ME, Weisenfeld D, Liao KP. McDermott GC, et al. Among authors: kawano y. Semin Arthritis Rheum. 2024 Jun;66:152421. doi: 10.1016/j.semarthrit.2024.152421. Epub 2024 Mar 1. Semin Arthritis Rheum. 2024. PMID: 38457949
Outcomes with and without outpatient SARS-CoV-2 treatment for patients with COVID-19 and systemic autoimmune rheumatic diseases: A retrospective cohort study.
Qian G, Wang X, Patel NJ, Kawano Y, Fu X, Cook CE, Vanni KMM, Kowalski EN, Banasiak EP, Bade KJ, Srivatsan S, Williams ZK, Todd DJ, Weinblatt ME, Wallace ZS, Sparks JA. Qian G, et al. Among authors: kawano y. medRxiv [Preprint]. 2022 Oct 30:2022.10.27.22281629. doi: 10.1101/2022.10.27.22281629. medRxiv. 2022. PMID: 36324801 Free PMC article. Updated. Preprint.
Outcomes with and without outpatient SARS-CoV-2 treatment for patients with COVID-19 and systemic autoimmune rheumatic diseases: a retrospective cohort study.
Qian G, Wang X, Patel NJ, Kawano Y, Fu X, Cook CE, Vanni KMM, Kowalski EN, Banasiak EP, Bade KJ, Srivatsan S, Williams ZK, Todd DJ, Weinblatt ME, Wallace ZS, Sparks JA. Qian G, et al. Among authors: kawano y. Lancet Rheumatol. 2023 Mar;5(3):e139-e150. doi: 10.1016/S2665-9913(23)00006-1. Epub 2023 Jan 23. Lancet Rheumatol. 2023. PMID: 36844970 Free PMC article.
Immunomodulators and risk for breakthrough infection after third COVID-19 mRNA vaccine among patients with rheumatoid arthritis: A cohort study.
Schiff AE, Wang X, Patel NJ, Kawano Y, Kowalski EN, Cook CE, Vanni KMM, Qian G, Bade KJ, Saavedra AA, Srivatsan S, Williams ZK, Venkat RK, Wallace ZS, Sparks JA. Schiff AE, et al. Among authors: kawano y. medRxiv [Preprint]. 2023 Oct 9:2023.10.08.23296717. doi: 10.1101/2023.10.08.23296717. medRxiv. 2023. PMID: 37873462 Free PMC article. Updated. Preprint.
Immunomodulators and risk for breakthrough COVID-19 after third SARS-CoV-2 mRNA vaccine among patients with rheumatoid arthritis: a cohort study.
Schiff AE, Wang X, Patel NJ, Kawano Y, Hanberg JL, Kowalski EN, Cook CE, Vanni KM, Qian G, Bade KJ, Saavedra AA, Srivatsan S, Williams ZK, Venkat RK, Wallace ZS, Sparks JA. Schiff AE, et al. Among authors: kawano y. Ann Rheum Dis. 2024 Apr 11;83(5):680-682. doi: 10.1136/ard-2023-225162. Ann Rheum Dis. 2024. PMID: 38199795 No abstract available.
2,325 results